Policy / Regulatory

NMPA Publishes 110th Batch of Chemical Generic Drug Reference Listed Drug Catalog – 28 New Specifications Added

NMPA Publishes 110th Batch of Chemical Generic Drug Reference Listed Drug Catalog – 28 New Specifications Added

The National Medical Products Administration (NMPA) has released the 110th batch of the Catalog of Reference Listed Drugs (RLD) for Chemical Generic Drugs, adding 28 new drug specifications and providing…

NMPA Proposes Drug Market Exclusivity Framework – Up to Seven Years for Rare Disease Therapies and Two Years for Pediatric Drugs

NMPA Proposes Drug Market Exclusivity Framework – Up to Seven Years for Rare Disease Therapies and Two Years for Pediatric Drugs

MOFCOM and MOST Open Consultation on Revised Technology Export Catalogue – 40 Technologies Across AI, Biopharmaceuticals and Photovoltaics Proposed for Addition

MOFCOM and MOST Open Consultation on Revised Technology Export Catalogue – 40 Technologies Across AI, Biopharmaceuticals and Photovoltaics Proposed for Addition

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
NHSA Finalizes 2025 Drug Catalog Adjustment Plan with Minimal Changes from Draft
Nationally negotiated drugsNHSA (prev. SMIA)

NHSA Finalizes 2025 Drug Catalog Adjustment Plan with Minimal Changes from Draft

NMPA Updates Review Procedures for Conditional Drug Marketing Approval Applications
NMPA

NMPA Updates Review Procedures for Conditional Drug Marketing Approval Applications

NMPA Releases 93rd Batch of Reference Drugs for Generic Quality Consistency Evaluation
NMPA

NMPA Releases 93rd Batch of Reference Drugs for Generic Quality Consistency Evaluation

China's CDE Announces 95th Batch of Reference Preparations for Public Comment
CDE

China’s CDE Announces 95th Batch of Reference Preparations for Public Comment

Show More